Intensity Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
INTS Key Statistics
Stock Snapshot
Intensity Therapeutics(INTS) stock is priced at $5.14, giving the company a market capitalization of 13.23M. It carries a P/E multiple of -0.45.
On 2026-05-05, Intensity Therapeutics(INTS) stock moved within a range of $5.06 to $5.34. With shares now at $5.14, the stock is trading +1.6% above its intraday low and -3.7% below the session's peak.
Trading activity shows a volume of 40.03K, compared to an average daily volume of 31.74K.
Over the past 52 weeks, Intensity Therapeutics(INTS) stock has traded between a high of $43.50 and a low of $4.63.
Over the past 52 weeks, Intensity Therapeutics(INTS) stock has traded between a high of $43.50 and a low of $4.63.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.